Confluence Pharmaceuticals
Carmel, US · 2 known investors
Biotech
Founders & leadership
BW
Boyd W. Sturdevant, Jr.Manager of the Issuer
SL
Steven L. JohnsPresident, CEO and Manager of the Issuer
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$10KraisedOct 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$10KraisedOct 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Phil LodatoDirector
- Steven L. JohnsExecutive Officer, Director
- Boyd W. Sturdevant, Jr.Director
- Offering amount
- $800K
- Amount sold
- $10K
- Minimum investment
- $10K
- First sale
- Sep 2018
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
▶$1.3MraisedNov 2016 · 10 investors · PharmaceuticalsRule 506(c)
▶$1.3MraisedNov 2016 · 10 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Boyd W. Sturdevant, Jr.Director
- Steven L. JohnsExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- Minimum investment
- $25K
- First sale
- Apr 2016
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.